{"transactions":[{"id":1759056,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":108947,"kind":"person","name":"Burgess Michael F.","position":1,"cik":"0001801745","reported_name":"Burgess Michael F.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-10-17T18:37:53.000Z","date":"2023-10-16","kind":"grant","planned":false,"acquired":true,"shares":11464,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth (1/4th) of the shares subject to the option award shall vest on October 12, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":11464,"derivative":{"exercise_price":2.61,"expiration_date":"2033-10-15","underlying":"Common Stock","underlying_shares":11464},"source":{"system":"sec-edgar","filing":"0001209191-23-052997","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801745/000120919123052997/doc4.xml","form_type":"4"}},{"id":1844282,"issuer":{"id":7801,"kind":"organization","name":"SYNLOGIC, INC."},"owners":[{"id":108947,"kind":"person","name":"Burgess Michael F.","position":1,"cik":"0001801745","reported_name":"Burgess Michael F.","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-06-26T14:21:50.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in full on the earlier of (A) the first anniversary of the date of grant or (B) immediately prior to the next annual meeting of the Corporation's stockholders after the date of grant, subject to the non-employee director's continued service as a director of the Corporation."}],"balance_after":30000,"derivative":{"exercise_price":0.504,"expiration_date":"2033-06-22","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000950170-23-029805","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801745/000095017023029805/ownership.xml","form_type":"4"}},{"id":2204586,"issuer":{"id":15910,"kind":"organization","name":"SpringWorks Therapeutics, Inc.","symbol":"SWTX"},"owners":[{"id":108947,"kind":"person","name":"Burgess Michael F.","position":1,"cik":"0001801745","reported_name":"Burgess Michael F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Common Stock","published_at":"2022-07-20T18:02:22.000Z","date":"2022-07-18","kind":"tax_withholding","acquired":false,"shares":3103,"price":28.47,"value":88342.41,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock awards and does not represent a sale by the Reporting Person."}],"balance_after":49584,"source":{"system":"sec-edgar","filing":"0001104659-22-081241","document":"tm2221493-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801745/000110465922081241/tm2221493-1_4seq1.xml","form_type":"4"}},{"id":2214874,"issuer":{"id":15910,"kind":"organization","name":"SpringWorks Therapeutics, Inc.","symbol":"SWTX"},"owners":[{"id":108947,"kind":"person","name":"Burgess Michael F.","position":1,"cik":"0001801745","reported_name":"Burgess Michael F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Common Stock","published_at":"2022-07-05T17:29:43.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":12185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents restricted stock awards, which became fully vested on June 30, 2022."}],"balance_after":52687,"source":{"system":"sec-edgar","filing":"0001104659-22-077447","document":"tm2220459-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801745/000110465922077447/tm2220459-1_4seq1.xml","form_type":"4"}},{"id":2214873,"issuer":{"id":15910,"kind":"organization","name":"SpringWorks Therapeutics, Inc.","symbol":"SWTX"},"owners":[{"id":108947,"kind":"person","name":"Burgess Michael F.","position":1,"cik":"0001801745","reported_name":"Burgess Michael F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Common Stock","published_at":"2022-07-05T17:29:43.000Z","date":"2022-06-01","kind":"tax_withholding","acquired":false,"shares":2672,"price":19.61,"value":52397.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock awards and does not represent a sale by the Reporting Person."}],"balance_after":40502,"source":{"system":"sec-edgar","filing":"0001104659-22-077447","document":"tm2220459-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801745/000110465922077447/tm2220459-1_4seq1.xml","form_type":"4"}},{"id":2234256,"issuer":{"id":7801,"kind":"organization","name":"SYNLOGIC, INC."},"owners":[{"id":108947,"kind":"person","name":"Burgess Michael F.","position":1,"cik":"0001801745","reported_name":"Burgess Michael F.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-13T16:15:41.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in full on the earlier of (A) the first anniversary of the date of grant or (B) immediately prior to the next annual meeting of the Corporation's stockholders after the date of grant, subject to the non-employee director's continued service as a director of the Corporation."}],"balance_after":27000,"derivative":{"exercise_price":1.17,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0000899243-22-022176","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801745/000089924322022176/doc4.xml","form_type":"4"}},{"id":2438972,"issuer":{"id":15910,"kind":"organization","name":"SpringWorks Therapeutics, Inc.","symbol":"SWTX"},"owners":[{"id":108947,"kind":"person","name":"Burgess Michael F.","position":1,"cik":"0001801745","reported_name":"Burgess Michael F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Stock Option  (Right to Buy)","published_at":"2022-01-10T16:23:47.000Z","date":"2022-01-06","kind":"grant","acquired":true,"shares":48852,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest in 48 equal monthly installments subject to continued service to the company by the Reporting Person."}],"balance_after":48852,"derivative":{"exercise_price":59.46,"expiration_date":"2032-01-06","underlying":"Common Stock","underlying_shares":48852},"source":{"system":"sec-edgar","filing":"0001104659-22-002741","document":"tm222382d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801745/000110465922002741/tm222382d3_4.xml","form_type":"4"}},{"id":2438971,"issuer":{"id":15910,"kind":"organization","name":"SpringWorks Therapeutics, Inc.","symbol":"SWTX"},"owners":[{"id":108947,"kind":"person","name":"Burgess Michael F.","position":1,"cik":"0001801745","reported_name":"Burgess Michael F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Common Stock","published_at":"2022-01-10T16:23:47.000Z","date":"2022-01-06","kind":"grant","acquired":true,"shares":15674,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction represents a grant of restricted stock units (\"RSUs\"). The RSUs shall vest as follows: thirty three percent (33%) to vest on January 6, 2023, another thirty three percent (33%) to vest on January 6, 2024 and the remaining thirty four percent (34%) to vest on January 6, 2025, such that the restricted stock awards are fully vested on January 6, 2025."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents a grant of restricted stock units (\"RSUs\"). The RSUs shall vest as follows: thirty three percent (33%) to vest on January 6, 2023, another thirty three percent (33%) to vest on January 6, 2024 and the remaining thirty four percent (34%) to vest on January 6, 2025, such that the restricted stock awards are fully vested on January 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction represents a grant of restricted stock units (\"RSUs\"). The RSUs shall vest as follows: thirty three percent (33%) to vest on January 6, 2023, another thirty three percent (33%) to vest on January 6, 2024 and the remaining thirty four percent (34%) to vest on January 6, 2025, such that the restricted stock awards are fully vested on January 6, 2025."}],"balance_after":43174,"source":{"system":"sec-edgar","filing":"0001104659-22-002741","document":"tm222382d3_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801745/000110465922002741/tm222382d3_4.xml","form_type":"4"}},{"id":2670340,"issuer":{"id":7801,"kind":"organization","name":"SYNLOGIC, INC."},"owners":[{"id":108947,"kind":"person","name":"Burgess Michael F.","position":1,"cik":"0001801745","reported_name":"Burgess Michael F.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-14T17:12:53.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in full on the earlier of (A) the first anniversary of the date of grant or (B) immediately prior to the next annual meeting of the Corporation's stockholders after the date of grant, subject to the non-employee director's continued service as a director of the Corporation."}],"balance_after":15000,"derivative":{"exercise_price":3.67,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-21-023616","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801745/000089924321023616/doc4.xml","form_type":"4"}},{"id":2689133,"issuer":{"id":15910,"kind":"organization","name":"SpringWorks Therapeutics, Inc.","symbol":"SWTX"},"owners":[{"id":108947,"kind":"person","name":"Burgess Michael F.","position":1,"cik":"0001801745","reported_name":"Burgess Michael F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-01T17:25:32.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest as follows: twenty five percent (25%) on June 1, 2022, and thereafter in thirty six (36) equal monthly installments until fully vested, subject to continued service to the Company by the Reporting Person."}],"balance_after":225000,"derivative":{"exercise_price":81.68,"expiration_date":"2031-06-01","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001104659-21-075168","document":"tm2114187-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801745/000110465921075168/tm2114187-2_4seq1.xml","form_type":"4"}},{"id":2689132,"issuer":{"id":15910,"kind":"organization","name":"SpringWorks Therapeutics, Inc.","symbol":"SWTX"},"owners":[{"id":108947,"kind":"person","name":"Burgess Michael F.","position":1,"cik":"0001801745","reported_name":"Burgess Michael F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Common Stock","published_at":"2021-06-01T17:25:32.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards. The restricted stock awards shall vest as follows: thirty three percent (33%) to vest on June 1, 2022, another thirty three percent (33%) to vest on June 1, 2023 and the remaining thirty four percent (34%) to vest on June 1, 2024, such that the restricted stock awards are fully vested on June 1, 2024, subject to continued service to the Company by the Reporting Person."}],"balance_after":27500,"source":{"system":"sec-edgar","filing":"0001104659-21-075168","document":"tm2114187-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801745/000110465921075168/tm2114187-2_4seq1.xml","form_type":"4"}},{"id":3118945,"issuer":{"id":7801,"kind":"organization","name":"SYNLOGIC, INC."},"owners":[{"id":108947,"kind":"person","name":"Burgess Michael F.","position":1,"cik":"0001801745","reported_name":"Burgess Michael F.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-08T17:31:46.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in full on the earlier of (A) the first anniversary of the date of grant or (B) immediately prior to the next annual meeting of the Corporation's stockholders after the date of grant, subject to the non-employee director's continued service as a director of the Corporation."}],"balance_after":15000,"derivative":{"exercise_price":2.22,"expiration_date":"2030-06-04","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-20-015647","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801745/000089924320015647/doc4.xml","form_type":"4"}},{"id":3292097,"issuer":{"id":7801,"kind":"organization","name":"SYNLOGIC, INC."},"owners":[{"id":108947,"kind":"person","name":"Burgess Michael F.","position":1,"cik":"0001801745","reported_name":"Burgess Michael F.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-02-04T16:32:48.000Z","date":"2020-02-03","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in substantially equal installments on each of the first three anniversaries of the Transaction Date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":2.51,"expiration_date":"2030-02-03","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-20-002806","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801745/000089924320002806/doc4.xml","form_type":"4"}}]}